Cargando…
Targeting the reversible drug-tolerant state: aurora kinase A, is that the final answer?
Autor principal: | Suda, Kenichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797747/ https://www.ncbi.nlm.nih.gov/pubmed/35117132 http://dx.doi.org/10.21037/tcr.2019.05.21 |
Ejemplares similares
-
Commentary: Malignant Glaucoma - Have we finally found an answer?
por: Kaushik, Sushmita
Publicado: (2019) -
Final Answer: Ghrelin Can Suppress Insulin Secretion in Humans, but Is It Clinically Relevant?
por: Meyer, Christian
Publicado: (2010) -
Solid Cancer Treatment With Aurora Kinase Inhibitors: Towards a Personalized Medicine
por: Ulisse, Salvatore
Publicado: (2017) -
Preclinical validation of Aurora kinases-targeting drugs in osteosarcoma
por: Tavanti, E, et al.
Publicado: (2013) -
Aurora Kinases as Targets in Drug-Resistant Neuroblastoma Cells
por: Michaelis, Martin, et al.
Publicado: (2014)